Active commuting (cycling)
UK Biobank (n=263,450): cycling commute associated with 41% lower all-cause mortality risk.
Why
Active commuting integrates exercise into a daily fixed routine, removing the willpower-cost of fitting workouts in. Celis-Morales 2017 BMJ analysis of 263,450 UK Biobank participants showed cycling commuters had 41% lower all-cause mortality, 52% lower cardiovascular mortality, and 40% lower cancer mortality vs. non-active commuters, over 5 years of follow-up. Walking commuters showed smaller but still meaningful effects.
How to do it
How
Replace one or more weekly car/transit commutes with cycling or walking. Build gradually. E-bikes count and reduce the barrier for longer or hilly routes.
Ideal for
Anyone with a feasible cycling distance (typically <15 km / <45 min one-way).
Markers this may influence
Evidence
Celis-Morales 2017 BMJ (UK Biobank, n=263,450, 5-y median follow-up): cycle commuting vs non-active commuting was associated with 41% lower all-cause mortality (HR 0.59) and 52% lower CVD mortality (HR 0.48). Walking commuting showed smaller but still meaningful effects. Observational, but the dose-response curve is steep and the cohort exhaustive.